Cargando…

Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency

OBJECTIVE: To raise awareness of Cytochrome P450 Oxidoreductase Deficiency (PORD, a rare form of congenital adrenal hyperplasia (CAH), through a case of pregnant woman with virilization symptoms. CASE DESCRIPTION: A 30-year-old Chinese woman was referred to hospital after 7 years of presenting signs...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jin, Woo, Kwan Leong, Hai, Yongxiong, Wang, Shimin, Lin, Ying, Huang, Ying, Peng, Xiaofang, Wu, HongShi, Zhang, Shaoling, Yan, Li, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742467/
https://www.ncbi.nlm.nih.gov/pubmed/36518257
http://dx.doi.org/10.3389/fendo.2022.1020880
_version_ 1784848525638500352
author Zhang, Jin
Woo, Kwan Leong
Hai, Yongxiong
Wang, Shimin
Lin, Ying
Huang, Ying
Peng, Xiaofang
Wu, HongShi
Zhang, Shaoling
Yan, Li
Li, Yan
author_facet Zhang, Jin
Woo, Kwan Leong
Hai, Yongxiong
Wang, Shimin
Lin, Ying
Huang, Ying
Peng, Xiaofang
Wu, HongShi
Zhang, Shaoling
Yan, Li
Li, Yan
author_sort Zhang, Jin
collection PubMed
description OBJECTIVE: To raise awareness of Cytochrome P450 Oxidoreductase Deficiency (PORD, a rare form of congenital adrenal hyperplasia (CAH), through a case of pregnant woman with virilization symptoms. CASE DESCRIPTION: A 30-year-old Chinese woman was referred to hospital after 7 years of presenting signs of virilization, including voice deepening, acromegaly, hirsutism, clitoromegaly, and acne. These symptoms appeared since her third gestation. Her second birth died 9 hours after birth and had signs of clitoris hypertrophy. Her third born was a son who presented with flat nose, radius and humerus bone malformation, and small penis at birth. Panel of POR-related genetic tests revealed that the patient carried c.1370 G>A (p.R457H), which is a POR heterozygous gene, while her husband carried a POR heterozygous gene as well, c.1379 C>A (p.S460Y). Two heterozygous mutations of the POR were found in her son: c.1370 G>A and c.1379 C>A. In PORD, c.1370 G>A (p.R457H) was reported as a susceptible gene, while c.1379 C>A (p.S460Y) has not been reported as responsible for the disease so far. DISCUSSION AND LITERATURE REVIEW: PORD is a rare form of CAH and caused by POR gene mutations. Most PORD patients are identified and diagnosed in pediatrics department. Internal medicine and obstetrics physicians are unfamiliar with the disease. As clinical manifestations are diverse, PORD could be easy to miss or to be misdiagnosed. Typical clinical manifestation includes adrenal insufficiency-related symptoms, such as bone malformations and sexual development disorders. PORD is diagnosed through genetic testing. Investigations of steroid metabolic products in urine through gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry are also helpful for the diagnosis, but neither of them are widely available in China. In this case, the patient had a history of infertility, and her third child was born with congenital defect and carried a PORD-related gene. In general clinical practice, if a pregnant woman presents with abnormal virilization symptoms, CAH possibilities should be considered, including rare causes such as PORD. CONCLUSION: PORD is a rare autosomal recessive genetic disease. We summarised the clinical characteristics and genotypes that were previously reported in the Chinese population and identified a novel mutation.
format Online
Article
Text
id pubmed-9742467
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97424672022-12-13 Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency Zhang, Jin Woo, Kwan Leong Hai, Yongxiong Wang, Shimin Lin, Ying Huang, Ying Peng, Xiaofang Wu, HongShi Zhang, Shaoling Yan, Li Li, Yan Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: To raise awareness of Cytochrome P450 Oxidoreductase Deficiency (PORD, a rare form of congenital adrenal hyperplasia (CAH), through a case of pregnant woman with virilization symptoms. CASE DESCRIPTION: A 30-year-old Chinese woman was referred to hospital after 7 years of presenting signs of virilization, including voice deepening, acromegaly, hirsutism, clitoromegaly, and acne. These symptoms appeared since her third gestation. Her second birth died 9 hours after birth and had signs of clitoris hypertrophy. Her third born was a son who presented with flat nose, radius and humerus bone malformation, and small penis at birth. Panel of POR-related genetic tests revealed that the patient carried c.1370 G>A (p.R457H), which is a POR heterozygous gene, while her husband carried a POR heterozygous gene as well, c.1379 C>A (p.S460Y). Two heterozygous mutations of the POR were found in her son: c.1370 G>A and c.1379 C>A. In PORD, c.1370 G>A (p.R457H) was reported as a susceptible gene, while c.1379 C>A (p.S460Y) has not been reported as responsible for the disease so far. DISCUSSION AND LITERATURE REVIEW: PORD is a rare form of CAH and caused by POR gene mutations. Most PORD patients are identified and diagnosed in pediatrics department. Internal medicine and obstetrics physicians are unfamiliar with the disease. As clinical manifestations are diverse, PORD could be easy to miss or to be misdiagnosed. Typical clinical manifestation includes adrenal insufficiency-related symptoms, such as bone malformations and sexual development disorders. PORD is diagnosed through genetic testing. Investigations of steroid metabolic products in urine through gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry are also helpful for the diagnosis, but neither of them are widely available in China. In this case, the patient had a history of infertility, and her third child was born with congenital defect and carried a PORD-related gene. In general clinical practice, if a pregnant woman presents with abnormal virilization symptoms, CAH possibilities should be considered, including rare causes such as PORD. CONCLUSION: PORD is a rare autosomal recessive genetic disease. We summarised the clinical characteristics and genotypes that were previously reported in the Chinese population and identified a novel mutation. Frontiers Media S.A. 2022-11-28 /pmc/articles/PMC9742467/ /pubmed/36518257 http://dx.doi.org/10.3389/fendo.2022.1020880 Text en Copyright © 2022 Zhang, Woo, Hai, Wang, Lin, Huang, Peng, Wu, Zhang, Yan and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zhang, Jin
Woo, Kwan Leong
Hai, Yongxiong
Wang, Shimin
Lin, Ying
Huang, Ying
Peng, Xiaofang
Wu, HongShi
Zhang, Shaoling
Yan, Li
Li, Yan
Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
title Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
title_full Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
title_fullStr Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
title_full_unstemmed Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
title_short Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
title_sort congenital adrenal hyperplasia due to p450 oxidoreductase deficiency
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742467/
https://www.ncbi.nlm.nih.gov/pubmed/36518257
http://dx.doi.org/10.3389/fendo.2022.1020880
work_keys_str_mv AT zhangjin congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT wookwanleong congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT haiyongxiong congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT wangshimin congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT linying congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT huangying congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT pengxiaofang congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT wuhongshi congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT zhangshaoling congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT yanli congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency
AT liyan congenitaladrenalhyperplasiaduetop450oxidoreductasedeficiency